Bioadhesive Gel Could Help Treat Diabetic Foot Ulcers
By HospiMedica International staff writers Posted on 09 May 2016 |
Image: Part of the equipment used for processing PRODERMA (Photo courtesy of the University of Barcelona).
A new project seeks to develop a sustained release matrix for the treatment of diabetic foot ulcer (DFU) that could improve the effectiveness of conventional treatments.
The collaboration between the University of Barcelona (UB, Spain), Ojer Pharma Laboratories (Pamplona, Spain), and Tecnalia Research & Innovation (Biscay, Spain) was formed to improve the efficiency of conventional topical treatments by developing a bioadhesive gel that combines cicatrizant properties with a topical antiseptic as indicated for the treatment of DFU, an illness that affects 15-20% of diabetics, and can lead to the amputation of the limb.
The project, dubbed PRODERMA, is based on an innovative production technique that facilitates the transport and administration of the active ingredients, thus improving the treatment of ulcerative DFU injuries. As part of the project, Tecnalia’s pharmaceutical development laboratory will select the candidate polymers and the topical antiseptics necessary to obtain a stable, safe, and effective formula. It will also provide analytical development and technological transfer along with the fine tuning, scaling and validation of the production processes under good manufacturing practice (GMP).
Diabetes patients often suffer from nerve and circulation problems in the feet, which reduce their perception of pain. The nerve pathways that ensure that weight is automatically transferred from one foot to the other during prolonged standing are disrupted, and as a result, diabetics do not notice that their toes, heels, or the balls of their feet are too heavily loaded. The foot receives no relief, and pressure sores, ulcers, and infections may go unnoticed; serious cases may even lead to amputation.
Related Links:
University of Barcelona
Ojer Pharma Laboratories
Tecnalia Research & Innovation
The collaboration between the University of Barcelona (UB, Spain), Ojer Pharma Laboratories (Pamplona, Spain), and Tecnalia Research & Innovation (Biscay, Spain) was formed to improve the efficiency of conventional topical treatments by developing a bioadhesive gel that combines cicatrizant properties with a topical antiseptic as indicated for the treatment of DFU, an illness that affects 15-20% of diabetics, and can lead to the amputation of the limb.
The project, dubbed PRODERMA, is based on an innovative production technique that facilitates the transport and administration of the active ingredients, thus improving the treatment of ulcerative DFU injuries. As part of the project, Tecnalia’s pharmaceutical development laboratory will select the candidate polymers and the topical antiseptics necessary to obtain a stable, safe, and effective formula. It will also provide analytical development and technological transfer along with the fine tuning, scaling and validation of the production processes under good manufacturing practice (GMP).
Diabetes patients often suffer from nerve and circulation problems in the feet, which reduce their perception of pain. The nerve pathways that ensure that weight is automatically transferred from one foot to the other during prolonged standing are disrupted, and as a result, diabetics do not notice that their toes, heels, or the balls of their feet are too heavily loaded. The foot receives no relief, and pressure sores, ulcers, and infections may go unnoticed; serious cases may even lead to amputation.
Related Links:
University of Barcelona
Ojer Pharma Laboratories
Tecnalia Research & Innovation
Latest Critical Care News
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergency Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure